syngene international: Live & Latest News Updates : Vimarsana.com

Stock Market Live Updates 26 April 2024 - The Hindu BusinessLine

biopharma companies: Expect Syngene revenue to grow from high single digits to low double digits next year: Jonathan Hunt

Jonathan Hunt detailed the investment strategy of Syngene International, facing revenue growth challenges due to US biotech funding delays. Expecting high single to low double digits growth for FY25, with ongoing developments in various company facilities. Hunt says: "We deployed $55 million last year. Next year, we will be a little bit ahead of that."

High single digit to low double digits revenue projections for FY 25: Syngene CEO

Management expressed positive long-term outlook for the sector and expressed confidence in Syngene's sustained performance on the back of improved fund flows into US biotech in the latter part of the year.

Syngene's biologics division expands amid Q4 downturn, expects strong revenue growth ahead

Company cites moderated performance in Q3 and Q4 leading to a slower latter half

Syngene International Q4 Results Live : profit rise by 5.48% YOY

Syngene International Q4 Results Live : Revenue decreased by 7.79% YoY & profit increasedby 5.48% YoY

Q4 results today: HUL, Axis Bank, LTIMindtree among 22 companies to announce earnings

Today marks a significant day for investors and market participants as several key companies from various sectors are set to announce their fourth-quarter results. Among the notable earnings releases, Hindustan Unilever (HUL), LTIMindtree, Indian Hotels, Axis Bank, Macrotech, and Tata Investment stand out.

HUL, Axis Bank to India Hotels, check out the list of companies to report Q4 results today

Q4 results today: Hindustan Unilever, Axis Bank, India Hotels are among a host of companies that will announce their 4th quarterly results today.

Share Market Highlights 24 April 2024: Sensex gains 114 pts, Nifty settles above 22,400

Syngene International March quarter net profit up 6% to Rs 189 crore, revenue down 8%

Syngene's revenue in the fourth quarter of the reported financial year fell seven percent on a year-on-year basis to Rs 916.9 crore, compared to Rs 994 crore in Q4FY23

Syngene Q4 Results: Net profit rises 6% to Rs 189 crore, revenue drops 8%

The earnings before interest, tax, depreciation and ammortisation dropped 1% YoY to Rs. 333 crore in Q4FY24. The EBITDA margin rose 300 basis points YoY to 36%.